GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » Price-to-Owner-Earnings

Cleo Diagnostics (ASX:COV) Price-to-Owner-Earnings : (As of May. 24, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Cleo Diagnostics Price-to-Owner-Earnings?

As of today (2024-05-24), Cleo Diagnostics's share price is A$0.17. Cleo Diagnostics does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Cleo Diagnostics's Price-to-Owner-Earnings or its related term are showing as below:


ASX:COV's Price-to-Owner-Earnings is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 33.29
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-05-24), Cleo Diagnostics's share price is A$0.17. Cleo Diagnostics does not have enough years/quarters to calculate the Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023. Therefore GuruFocus does not calculate PE Ratio at this moment.

As of today (2024-05-24), Cleo Diagnostics's share price is A$0.17. Cleo Diagnostics does not have enough years/quarters to calculate the EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023. Therefore GuruFocus does not calculate PE Ratio without NRI at this moment.


Cleo Diagnostics Price-to-Owner-Earnings Historical Data

The historical data trend for Cleo Diagnostics's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleo Diagnostics Price-to-Owner-Earnings Chart

Cleo Diagnostics Annual Data
Trend Jun23
Price-to-Owner-Earnings
-

Cleo Diagnostics Semi-Annual Data
Dec22 Jun23 Dec23
Price-to-Owner-Earnings - - -

Competitive Comparison of Cleo Diagnostics's Price-to-Owner-Earnings

For the Medical Devices subindustry, Cleo Diagnostics's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cleo Diagnostics's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cleo Diagnostics's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Cleo Diagnostics's Price-to-Owner-Earnings falls into.



Cleo Diagnostics Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Cleo Diagnostics's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.17/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cleo Diagnostics  (ASX:COV) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Cleo Diagnostics Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Cleo Diagnostics's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Cleo Diagnostics (ASX:COV) Business Description

Traded in Other Exchanges
N/A
Address
480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000
Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The Company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.

Cleo Diagnostics (ASX:COV) Headlines

No Headlines